Al-Sawaf O, Jen M-H, Hess LM, Zhang J, Goebel B, Pagel JM, Abhyankar S, Davids MS, Eyre TA. Pirtobrutinib <i>versus</i&gt; venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparison. Haematologica 2024;109(6):1866-1873; https://doi.org/10.3324/haematol.2023.284150.